These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26228524)

  • 41. Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
    Baker DA; Madayag A; Kristiansen LV; Meador-Woodruff JH; Haroutunian V; Raju I
    Neuropsychopharmacology; 2008 Jun; 33(7):1760-72. PubMed ID: 17728701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
    Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA
    Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A decrease in protein level and a missense polymorphism of KIF17 are associated with schizophrenia.
    Ratta-Apha W; Mouri K; Boku S; Ishiguro H; Okazaki S; Otsuka I; Sora I; Arinami T; Shirakawa O; Hishimoto A
    Psychiatry Res; 2015 Dec; 230(2):424-9. PubMed ID: 26421900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
    Arion D; Corradi JP; Tang S; Datta D; Boothe F; He A; Cacace AM; Zaczek R; Albright CF; Tseng G; Lewis DA
    Mol Psychiatry; 2015 Nov; 20(11):1397-405. PubMed ID: 25560755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanisms and timing of cortical immune activation in schizophrenia.
    Volk DW; Chitrapu A; Edelson JR; Roman KM; Moroco AE; Lewis DA
    Am J Psychiatry; 2015 Nov; 172(11):1112-21. PubMed ID: 26133963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-4763-3p targeting
    Wang J; Qi W; Shi H; Huang L; Ning F; Wang F; Wang K; Bai H; Wu H; Zhuang J; Hong H; Zhou H; Feng H; Zhou Y; Dong N; Liu L; Kong Y; Xie J; Zhao RC
    Aging Dis; 2022 Jul; 13(4):1278-1292. PubMed ID: 35855328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action.
    Celada P; Lladó-Pelfort L; Santana N; Kargieman L; Troyano-Rodriguez E; Riga MS; Artigas F
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2145-63. PubMed ID: 23809188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
    Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
    Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.
    Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A
    Mol Cell Neurosci; 2008 Feb; 37(2):335-45. PubMed ID: 18035555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency.
    Karl T; Chesworth R; Duffy L; Herzog H
    Behav Brain Res; 2010 Mar; 207(2):434-40. PubMed ID: 19879900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
    Gupta DS; McCullumsmith RE; Beneyto M; Haroutunian V; Davis KL; Meador-Woodruff JH
    Synapse; 2005 Sep; 57(3):123-31. PubMed ID: 15945063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs.
    Lipska BK; Peters T; Hyde TM; Halim N; Horowitz C; Mitkus S; Weickert CS; Matsumoto M; Sawa A; Straub RE; Vakkalanka R; Herman MM; Weinberger DR; Kleinman JE
    Hum Mol Genet; 2006 Apr; 15(8):1245-58. PubMed ID: 16510495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia.
    Joshi D; Fullerton JM; Weickert CS
    J Psychiatr Res; 2014 Jun; 53():125-32. PubMed ID: 24636039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible contribution of epigenetic changes in the development of schizophrenia-like behavior in vasopressin-deficient Brattleboro rats.
    Demeter K; Török B; Fodor A; Varga J; Ferenczi S; Kovács KJ; Eszik I; Szegedi V; Zelena D
    Behav Brain Res; 2016 Mar; 300():123-34. PubMed ID: 26704217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of SPAK knockout on sensorimotor gating, novelty exploration, and brain area-dependent expressions of NKCC1 and KCC2 in a mouse model of schizophrenia.
    Yang SS; Huang CL; Chen HE; Tung CS; Shih HP; Liu YP
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():30-6. PubMed ID: 25797415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia.
    Molina V; Solera S; Sanz J; Sarramea F; Luque R; Rodríguez R; Jiménez-Arriero MA; Palomo T
    Psychiatry Res; 2009 Aug; 173(2):88-93. PubMed ID: 19559574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia.
    Koga M; Ishiguro H; Yazaki S; Horiuchi Y; Arai M; Niizato K; Iritani S; Itokawa M; Inada T; Iwata N; Ozaki N; Ujike H; Kunugi H; Sasaki T; Takahashi M; Watanabe Y; Someya T; Kakita A; Takahashi H; Nawa H; Muchardt C; Yaniv M; Arinami T
    Hum Mol Genet; 2009 Jul; 18(13):2483-94. PubMed ID: 19363039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.
    Takahashi N; Nielsen KS; Aleksic B; Petersen S; Ikeda M; Kushima I; Vacaresse N; Ujike H; Iwata N; Dubreuil V; Mirza N; Sakurai T; Ozaki N; Buxbaum JD; Sap J
    Biol Psychiatry; 2011 Oct; 70(7):626-35. PubMed ID: 21831360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.